Javascript must be enabled to continue!
CD34+ Marrow Cells from MDS Patients Express Homing-Associated Cell Surface Molecules but Impaired In Vitro Migration.
View through CrossRef
Abstract
Homing and retention of hematopoietic stem cells in the marrow microenvironment are multi-step processes mainly controlled by interactions between chemokines, adhesion receptors and proteases. In the case of MDS, whether these interactions are perturbed and how they are implicated in the pathogenesis of the disease or progression to AML is not known. In this study we evaluated the cell surface expression of homing-associated adhesion molecules, CD11a, CD26, CD45, CD49d, CD49e and CXCR4 by flow cytometric analysis in BM mononuclear (MN) and CD34+ cells from 19 MDS patients [7 RA, 1RARS, 11RAEB(t)] and age-matched healthy individuals (n=9). CD34+ and MN cells from RAEB(t) samples expressed higher levels of CD11a and CD49e (2–3 fold increase) and 1,5–3 fold lower levels of CD45 compared with the cells from the healthy control group, as measured by the mean fluorescent intensity. None of the remaining molecules was found to have altered expression in the RAEB(t) subtype. A similar expression pattern of all homing-associated molecules was seen in the cells from the RA/RARS and normal control samples. However, when CD34+ cells from MDS patients were allowed to migrate in vitro toward a gradient of SDF-1α (125ng/ml), they displayed an impaired chemotactic response [mean values of % input: 9% (0,5–30%)], whereas those from healthy individuals actively migrated [mean values of % input: 20% (10–50%)]. Both migrated and non migrated CD34+ cells from MDS patients displayed little hematopoietic activity in vitro (CFC and LTC-IC). The addition of neutralizing monoclonal antibody anti-CXCR4 decreased in vitro chemotactic response of normal and MDS derived CD34+ cells by 90% and 80% respectively indicating that migration was dependent on SDF1/CXCR4 interactions. To further investigate the differences observed in response to SDF1a, immunofluorescence detection of intracellular expression of CXCR4 was performed. MDS derived CD34+ and MN cells from all the subtypes studied significantly expressed high levels of intracellular CXCR4 and were induced to cell surface CXCR4 expression after 48 hours of SCF (100ng/ml) and IL-6 (20ng/ml) stimulation, as was seen with normal cells.
In conclusion marrow CD34+ cells from MDS patients showed reduced capacity to migrate in vitro, although no significant perturbations of adhesion molecules expression were detected. We are currently investigating the signaling events and pathways, which control homing and adhesion of hematopoietic cells in the marrow.
American Society of Hematology
Title: CD34+ Marrow Cells from MDS Patients Express Homing-Associated Cell Surface Molecules but Impaired In Vitro Migration.
Description:
Abstract
Homing and retention of hematopoietic stem cells in the marrow microenvironment are multi-step processes mainly controlled by interactions between chemokines, adhesion receptors and proteases.
In the case of MDS, whether these interactions are perturbed and how they are implicated in the pathogenesis of the disease or progression to AML is not known.
In this study we evaluated the cell surface expression of homing-associated adhesion molecules, CD11a, CD26, CD45, CD49d, CD49e and CXCR4 by flow cytometric analysis in BM mononuclear (MN) and CD34+ cells from 19 MDS patients [7 RA, 1RARS, 11RAEB(t)] and age-matched healthy individuals (n=9).
CD34+ and MN cells from RAEB(t) samples expressed higher levels of CD11a and CD49e (2–3 fold increase) and 1,5–3 fold lower levels of CD45 compared with the cells from the healthy control group, as measured by the mean fluorescent intensity.
None of the remaining molecules was found to have altered expression in the RAEB(t) subtype.
A similar expression pattern of all homing-associated molecules was seen in the cells from the RA/RARS and normal control samples.
However, when CD34+ cells from MDS patients were allowed to migrate in vitro toward a gradient of SDF-1α (125ng/ml), they displayed an impaired chemotactic response [mean values of % input: 9% (0,5–30%)], whereas those from healthy individuals actively migrated [mean values of % input: 20% (10–50%)].
Both migrated and non migrated CD34+ cells from MDS patients displayed little hematopoietic activity in vitro (CFC and LTC-IC).
The addition of neutralizing monoclonal antibody anti-CXCR4 decreased in vitro chemotactic response of normal and MDS derived CD34+ cells by 90% and 80% respectively indicating that migration was dependent on SDF1/CXCR4 interactions.
To further investigate the differences observed in response to SDF1a, immunofluorescence detection of intracellular expression of CXCR4 was performed.
MDS derived CD34+ and MN cells from all the subtypes studied significantly expressed high levels of intracellular CXCR4 and were induced to cell surface CXCR4 expression after 48 hours of SCF (100ng/ml) and IL-6 (20ng/ml) stimulation, as was seen with normal cells.
In conclusion marrow CD34+ cells from MDS patients showed reduced capacity to migrate in vitro, although no significant perturbations of adhesion molecules expression were detected.
We are currently investigating the signaling events and pathways, which control homing and adhesion of hematopoietic cells in the marrow.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Mechanism of Action of Azacytidine in Myelodysplastic Syndromes (MDS)
Mechanism of Action of Azacytidine in Myelodysplastic Syndromes (MDS)
Abstract
Introduction: Myelodysplastic syndromes (MDS) have historically been classified as a set of heterogeneous hematopoietic stem cell (HSC) disorders, which are...
Disulfram/Copper Complex May Enhance Its Cytotoxic Effect on CD34+CD38- KG1-Alpha Cells By Down Regulating the Expression of HIF1-Alpha in the Co-Cultured MSCs
Disulfram/Copper Complex May Enhance Its Cytotoxic Effect on CD34+CD38- KG1-Alpha Cells By Down Regulating the Expression of HIF1-Alpha in the Co-Cultured MSCs
Abstract
Backgroud We had reported that Disulfram/copper complex (DS/ Cu) had a potent and selective anti-leukemia property in vitro against leukemia stem-like cells...
Higher Percentage of CD34+CD38− Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predict Unsustained Complete Remission in AML
Higher Percentage of CD34+CD38− Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predict Unsustained Complete Remission in AML
Abstract
Abstract 1485
Aim:
Myeloablative chemotherapy followed by autologous PBSCT remains one treatment strateg...
Isolation and Characterization of a CD34+ Sub-Clone in B-Cell Lymphoma
Isolation and Characterization of a CD34+ Sub-Clone in B-Cell Lymphoma
Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy in the US. Many types remain incurable despite response to initial therapy and achievement of complete remi...
Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.
Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.
Abstract
Abstract 2766
Poster Board II-742
(Introduction)
B7-H1 (CD274) is a costimulatory/coinhib...
FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes
FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes
Abstract
Abstract 232
Background:
Low risk myelodysplastic syndromes (MDS) CD34-positive cells exhibit high level...
Development and Exploitation of a Fully Human and Modular Organotypic Bone Marrow Niche Model to Study the Role of Stroma-Produced Factors in Human MDS
Development and Exploitation of a Fully Human and Modular Organotypic Bone Marrow Niche Model to Study the Role of Stroma-Produced Factors in Human MDS
Background: Myelodysplastic syndromes (MDS) are a heterogenous group of stem cell driven disorders primarily affecting the elderly and characterized by inefficient production of ma...

